Maria Brotons Agullo
Researcher
Maria Brotons holds a Medical degree (University of Barcelona-UB, 2005), a Master’s degree in Public Health (University Pompeu Fabra-UPF, 2007), and a Medical Specialty in Preventive Medicine and Public Health (Vall d’Hebron University Hospital, 2010)
In 2010 she joined the Cancer Epidemiology Research Program (PREC) in the Catalan Institute of Oncology (ICO) as epidemiologist, and her research topics focus on the epidemiology and prevention of human papillomavirus (HPV) infections and related diseases.
When she joined the PREC, she was involved in the HPV Information Center, a web-based resource lead by ICO and the International Agency for Research on Cancer (IARC) that aims to compile and centralize worldwide updated data and statistics on HPV and related diseases to accelerate the introduction of HPV preventive strategies. As part of the HPV-Information Centre, she participated in several international projects and in a consultancy requested by the European Centre for Disease Prevention and Control (ECDC) to update the HPV vaccination guidelines in the European Union.
Currently, she is a member of the UNIC-I team and her work focuses on the evaluation of the impact of cervical cancer preventative strategies, mainly HPV vaccination. She leads the studies to evaluate the impact of the HPV vaccine introduction in Catalonia, in collaboration with the Catalan Health Department, and these studies are the basis of her thesis project on the impact of HPV vaccination in Catalonia.
She is currently collaborating with the Pan American Health Organization (PAHO) to develop a guideline to assess the impact of HPV vaccination in Latin America. The objectives of this guideline are to provide conceptual and methodological guidance to Latin American and Caribbean countries on measuring the impact of HPV vaccination.
ORCID: orcid.org/0000-0002-3057-0616
Email: mbrotons@iconcologia.net
SELECTED PUBLICATIONS:
Brotons M, Monfil L, Roura E, et al. Impact of a single-age cohort human papillomavirus vaccination strategy in Catalonia, Spain: Population-based analysis of anogenital warts in men and women. Preventive Medicine. 2020 Sep;138:106166. doi: 10.1016/j.ypmed.2020.10616610.1016/j.ypmed.2020.106166
Brotons M, Bruni L. Population-level impact of human papillomavirus vaccination. The Lancet. 2020 Feb;395(10222):411–2. doi: 10.1016/S0140-6736(19)33153-8
de Sanjose S, Brotons M, LaMontagne DS, et al. Human papillomavirus vaccine disease impact beyond expectations. Curr Opin Virol. 2019 Aug 2;39:16–22. doi: 10.1016/j.coviro.2019.06.006
Serrano B, Brotons M, Bosch FX, et al. Epidemiology and burden of HPV related disease. Best Pract Res Clin Obstet Gynaecol. 2018 Feb;47:14-26. doi: 10.1016/j.bpobgyn.2017.08.006
de Sanjosé S, Brotons M, Pavon MA. The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol. 2018 Feb;47:2-13. doi: 10.1016/j.bpobgyn.2017.08.015
Bosch FX, Broker TR, Forman D, (…) Brotons M, et al. Comprehensive Control of Human Papillomavirus Infections and Related Diseases. Vaccine 2013;31 Suppl 8:I1-31. doi: 10.1016/j.vaccine.2013.07.026
Poljak M, Rogovskaya SI, Kesić V, (…) Brotons M, et al. Recommendations for cervical cancer prevention in central and eastern europe and central Asia. Vaccine. 2013;31 Suppl 7:H80–82. doi: 10.1016/j.vaccine.2013.04.038
Rogovskaya SI, Shabalova IP, Mikheeva IV, (…) Brotons M, et al. Human Papillomavirus Prevalence and Type-Distribution, Cervical Cancer Screening Practices and Current Status of Vaccination Implementation in Russian Federation, the Western Countries of the former Soviet Union, Caucasus Region and Central Asia. Vaccine. 2013;31 Suppl 7:H46–58. doi: 10.1016/j.vaccine.2013.06.043
Bray F, Lortet-Tieulent J, Znaor A, Brotons M, et al. Patterns and trends in human papillomavirus-related diseases in central and eastern europe and central Asia. Vaccine. 2013;31 Suppl 7:H32–45. doi: 10.1016/j.vaccine.2013.02.071
Hartwig S., Syrjanen S., Dominiak-Felden G., Brotons M., et al. Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review. BMC Cancer. 2012 Ene 20;12(1):30. doi: 10.1186/1471-2407-12-30